PTGS2 and colorectal carcinoma: It is known that the expression of COX-2 is regulated at transcriptional and translational levels, therefore it is of great significance to find novel factors acting at the above two levels to regulate COX-2 expression, which would facilitate new therapeutic development for CRC.